Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | K2 Transfection System | publication | P. D’Arrigo et al., Oncotarget, 2017, 8 (40): 68291-68304 | Link | |||
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | |||
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
Daoy |
Human desmoplastic cerebellar medulloblastoma cell line | ATCC HTB-186 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M.C. Burger et al., Int. J. of Oncology, 2012, 41: 235-241, DOI: 10.3892/ijo.2012.1446 | Link | |
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. J. Choi et al., Cancer Res., Apr 2007; 67: 3654 - 3662 | Link | |
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | plasmid | Metafectene PRO | publication | C. Morich, Dissertation, 2016, Georg-August University Göttingen | Link | ||
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | S.-B. Varda et al., 2012, EP 2 371 846 | Link | ||
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | V. Shoshan-Barmatz et al., 2014, US 8,648,045 (Patent) | Link | ||
GH3 |
Rat pituitary gland neoplasm cancer cell line (somatotropic) | ATCC ® ATCC CCL82.1 | Rat | brain | cell line | adherent | plasmid | Metafectene PRO | publication | G. Brigantea et al., Mol. and Cell. Endocrinology, 2019, 482: 37–44, doi.org/10.1016/j.mce.2018.12.005 | Link | ||
GL15 |
Human glioblastoma cell line | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | R. Xie et al., Oncology Reports, 2013, 29: 177-184, 2013, DOI: 10.3892/or.2012.2102 | Link | ||
GL15 |
Human glioblastoma cell line | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene | publication | R. Xie et al., Oncology Reports, 2013, 29: 177-184, 2013, DOI: 10.3892/or.2012.2102 | Link | ||
H4 |
Human neuroglioma cell line | ATCC HTB148 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | L. Fonseca-Ornelas et al., Nature Commun., 2014, 5:5857, DOI: 10.1038/ncomms6857 | Link | ||
H4 |
Human neuroglioma cell line | ATCC HTB148 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | D. Dias Queiroz et al., Res. Square, 2021, doi.org/10.21203/rs.3.rs-1075440/v1 | Link | ||
H4 |
Human neuroglioma cell line | ATCC HTB148 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | K. Albert et al., Mol. Therapy, 2021, 29: 9, doi.org/10.1016/j.ymthe.2021.04.035 | Link | ||
hCMEC/D3 |
Human brain-derived microvascular endothelial cells | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Krishnan et al.,Oncotarget, 2015, 6(26): 22480-22495 | Link | ||
HT-22 |
Mouse hippocampal neuronal cell line | Mouse | brain | cell line | adherent | plasmid | Metafectene | application note | ![]() |
||||
HT-22 |
Mouse hippocampal neuronal cell line | Mouse | brain | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
HT-22 |
Mouse hippocampal neuronal cell line | Mouse | brain | cell line | adherent | plasmid | high troughput application | Metafectene | publication | J. Zitzler et al., Mol. Cell. Proteomics, Aug 2004; 3: 834 - 840 | Link | ||
HW3-5 |
Mouse hippocampal cell line | Mouse | brain | cell line | adherent | plasmid | Metafectene | publication | T. Barz et al., Cancer Res., Dec 2006; 66: 11975 - 11982 | Link | |||
LAN1 |
Human neuroblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. Groß et al., Cancer Res., 2018, DOI: 10.1158/0008-5472.CAN-17-1860 | |||
LN-18 |
Human brain glioblastoma cell line | ATCC CRL-2610 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | G. D. Maurer et al., Neuro Oncology, Dec 2009; 11: 747 - 756 | Link | |
LN-18 |
Human brain glioblastoma cell line | ATCC CRL-2610 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | G. D. Maurer et al., Neuro Oncology, Dec 2009; 11: 747 - 756 | Link | |
LN-18 |
Human brain glioblastoma cell line | ATCC CRL-2610 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | C. Happold et al., Mol. Cancer Ther., Apr 2014; 13: 948 - 961 | Link |